Gene Query: UHRF1

Dataset Description Geneva Score
MYCi361 regulates MYC target genes 124.97
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 101.29
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 99.03
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 99.03
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 89.09
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 84.38
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 83.98
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 74.88
Gene expression analysis of dengue-infected cells 72.13
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 67.21
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 67.21
RNA-seq of shEZH2 cells 66.39
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 63.7
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 61.19
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 59.61
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 58.31
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 58.06
NR2F2 study 57.49
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 57.49
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 57.02
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 56.43
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 56.03
Gene expression changes caused by KRAS in MCF-10A 53.74
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 52.99
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 52.56
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 52.56
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 51.53
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 51.53
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 51.13
Genome wide expression change by RNF168 knocking down in MCF-7 cells 50.83
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 48.88
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 48.26
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 48.03
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 46.96
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 46.1
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 46.0
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 46.0
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 45.11
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 44.85
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 44.8
Identification of Sin3B regulated genes during quiescence 44.41
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 43.42
Identification of global regulators of T-helper cell lineage specification 43.42
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 43.21
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 42.83
mRNA-Seq profiling of human developing kidney 42.01
MCF10A H-Ras RNA-Seq 41.89
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 41.19
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 41.09
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 41.09
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 40.37
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 40.3
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 39.8
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 39.77
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 39.74
Expression level comparison under dividing and quiescent states in human primary fibroblasts 39.63
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 39.07
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 39.05
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 38.71
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 38.66
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 38.62
Effect of FGF13 depletion on the H460 cell line 38.58
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 37.91
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 37.89
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 37.75
RNA-seq of resting and activated CD4+ T cells +-JQ1 37.68
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 37.21
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 36.63
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 36.6
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 36.55
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 36.44
LncRNA-GAS5 negative regulation of YAP-target genes expression 36.43
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 36.12
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 36.11
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 35.64
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 35.46
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 35.38
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 35.37
Genome-wide transcriptional response to random aneuploidy in human cells 35.12
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 34.98
The landscape of alternative splicing in aggressive prostate cancers 34.47
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 34.16
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 34.02
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 33.8
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 33.74
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 33.27
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 33.27
Gene induction by the USP6 oncogene in response to interferon 33.24
A549 cells and MSR-A549 cells 32.83
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 32.83
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 32.54
Transcriptional profiles of normal human mature B cells 32.44
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 32.32
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 32.31
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 32.25
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 31.98
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 31.82
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 31.63
A code of mono-phosphorylation modulates the function of RB. 31.52
Transcriptional responses of human insulinoma cells to acute cytokine exposure 31.13
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 30.79
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 30.68
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 30.22
Overexpression and knockdown experiment for circCSNK1G3 30.17
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 30.15
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 30.07
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 30.07
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 29.68
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 29.37
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 29.26
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 29.18
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 29.16
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 29.15
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 29.07
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 29.0
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 28.85
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 28.85
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 28.7
RNA-seq analysis of uveal melanoma cells treated with FR900359 28.46
Transcriptome analysis of U87 cells upon LINC00152 knockdown 28.31
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 28.24
Generation of trichogenic adipose-derived stem cells by expression of three factors 28.02
Zika infected neural stem cells 27.95
Transcriptome analysis of Zika infected neural stem cells 27.95
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 27.95
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 27.95
Studying the selectivity of a small molecule Synucleozid on transcriptome 27.92
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 27.86
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 27.81
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 27.72
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 27.25
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 27.09
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 27.0
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 27.0
Genome-wide analysis of the Integrator complex (HTS) 26.84
Genome-wide analysis of the Integrator complex 26.84
FOXD3 is a novel tumor suppressor in lung cancer 26.66
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 26.6
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 26.54
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 26.14
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 26.1
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 26.09
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 26.07
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 26.04
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 26.04
The regulartory role of ZCCHC24 in splicing machinery 25.89
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 25.86
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 25.72
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 25.66
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 25.65
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 25.65
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 25.61
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 25.52
Genome-wide chromatin analysis of Ewing sarcoma 25.52
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 25.52
Neurofibroma 25.52
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 25.44
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 25.44
Aneuploidy triggers an immune response 25.43
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 25.25
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 25.14
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 25.01
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 25.0
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 25.0
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 24.87
Retinoic acid suppresses MYB in adenoid cystic carcinoma 24.73
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 24.73
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 24.64
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 24.59
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 24.47
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 24.39
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 24.36
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 24.15
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 24.15
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 24.0
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 23.97
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 23.79
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 23.63
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 23.28
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 23.27
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 23.22
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 23.17
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 23.17
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 23.1
Maturation of human iNSCs 22.92
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 22.72
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 22.71
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 22.71
Aneuploidy-induced cellular stresses limit autophagic degradation. 22.6
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 22.59
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 22.35
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 22.35
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 22.31
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 22.19
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 22.19
Cell responses to dysregulated VZV-induced cell-cell fusion 22.16
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 22.08
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 22.06
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 21.93
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 21.88
Downregulation of DDX5/DDX17 and REST 21.86
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 21.8
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 21.8
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 21.74
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 21.68
IRF2 is a master regulator of human keratinocyte stem cell fate 21.68
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 21.6
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 21.53
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 21.53
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 21.39
Bone marrow derived human B cells [normal proB] 21.37
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 21.25
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 21.25
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 21.21
Chromatin landscape of human visceral and subcutaneous adipocytes 21.18
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 21.03
HBEC-shp53-PCHD7 21.02
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 21.01
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 20.95
Transcriptome analysis of BAP1 knockout and restoration 20.85
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 20.85
RNA-seq of young and quiescent MRC-5 human fibroblasts 20.79
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 20.77
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 20.64
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 20.64
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 20.63
Differential gene expression of human melanoma cells [RNA-seq] 20.63
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 20.61
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 20.57
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 20.57
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 20.52
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 20.52
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 20.47
Effect of CHKA knockdown on C4-2 cell transcriptome 20.42
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 20.4
FOXP2's impact on the primate transcriptome 20.39
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 20.35
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 20.28
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 20.24
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 20.15
The effect of insulin on mRNA transcription of human pluripotent stem cells 20.05
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 19.95
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 19.85
STRIPAK directs PP2A activity to promote oncogenic transformation 19.78
CSL RNA-Seq on HKC and SCC cell lines 19.74
CSL 19.74
A map of gene expression in neutrophil-like cell lines 19.61
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 19.61
Effect of mitochondria deficiency on senescence-associated gene expression 19.57
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 19.57
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 19.57
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 19.55
Differential gene expression in Jagged1 treated human dental pulp cells. 19.43
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 19.35
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 19.35
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 19.31
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 19.28
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 19.15
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 19.14
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 19.14
Conservative alteration of chromosomal expression pattern across human solid tumor types 19.11
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 18.95
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 18.91
RNA-seq of YB5 cells treated with Proscillaridin A 18.89
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 18.76
Differential analysis of gene regulation at transcript resolution by RNA-Seq 18.72
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 18.72
EGR1-controlled transcriptome of T HESCs 18.69
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 18.64
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 18.61
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 18.57
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 18.57
Paxillin regulates genomic networks in prostate cancer [PC3] 18.38
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 18.38
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 18.36
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 18.0
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 17.99
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 17.97
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 17.94
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 17.91
SNHG5 siRNA knock down in HCT116 cells 17.81
17.66
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 17.64
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 17.57
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 17.51
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 17.46
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 17.4
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 16.99
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 16.87
Genome-wide analysis of Dengue virus 2 infected cells 16.84
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 16.81
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 16.7
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 16.62
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 16.59
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 16.54
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 16.54
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 16.5
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 16.46
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 16.32
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 15.99
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 15.95
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 15.88
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 15.88
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 15.86
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 15.74
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 15.68
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 15.68
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 15.68
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 15.66
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 15.47
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 15.41
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 15.4
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 15.33
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 15.31
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 15.01
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 14.83
Identification of differentially expressed genes between senescence and senescence bypass cells 14.69
Transcriptional profiling of LS1034 cells treated with tepoxalin 14.69
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 14.54
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 14.54
MCF-7 as a model for functional analysis of breast cancer risk variants 14.36
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 14.35
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 14.27
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 14.0
Ro60-knockout cells 13.98
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 13.9
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 13.9
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 13.88
Effect of from Human Umbilical Vein Endothelial Cells 13.87
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 13.8
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 13.56
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 13.55
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 13.55
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 13.51
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 13.43
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 13.43
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 13.42
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 13.22
RNA-seq analysis of BAP1-depleted uveal melanoma cells 13.03
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 12.76
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 12.73
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 12.73
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 12.61
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 12.61
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 12.46
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 12.46
Regulation of hypoxia-inducible factor activity by ZMYND8 12.13
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 12.07
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 12.07
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 11.75
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 11.71
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 11.71
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 11.64
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 11.62
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 11.36
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 11.21
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 11.21
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 11.2
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 11.18
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 11.18
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 11.03
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 11.02
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 10.91
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 10.91
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 10.86
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 10.81
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 10.76
RNAseq of cell lines with knocked in ESR1 mutations 10.57
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 10.26
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 10.21
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 10.16
CHD1 regulates cell fate determination by activation of differentiation-induced genes 10.11
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 10.03
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 9.94
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 9.9
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 9.81
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 9.74
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 9.69
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 9.64
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 9.56
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 9.34
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 9.32
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 9.3
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 9.29
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 9.17
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 8.99
Proliferation-correlated expression 8.78
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 8.66
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 8.63
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 8.23
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 8.23
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 8.21
The pioneer factor CEBPA modulates vitamin D signaling 8.15
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 8.15
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 8.08
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 8.01
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 7.99
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 7.94
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 7.93
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 7.92
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 7.84
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 7.7
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 7.59
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 7.48
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 7.33
6mer seed toxicity in tumour suppressive microRNAs 7.28
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 7.28
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 7.22
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 7.18
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 7.08
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  6.99
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 6.89
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 6.59
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 6.41
6mer seed toxicity in viral microRNAs 6.36
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 6.34
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 6.33
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 6.12
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 6.12
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 5.96
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 5.91
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 5.89
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 5.73
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 5.61
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 5.58
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 5.58
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 5.49
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 5.32
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 5.0
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 4.96
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 4.92
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 4.9
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 4.84
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 4.72
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 4.68
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 4.67
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 4.37
Entrectinib Resistance in a Neuroblastoma Xenograft Model 4.36
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 4.27
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 4.21
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 4.18
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 4.11
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 3.81
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 3.76
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 3.55
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 3.34
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 3.34
Zika virus infection reprograms global transcription of host cells to allow sustained infection 3.28
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 3.26
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 3.26
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 3.11
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 3.11
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 3.06
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 3.05
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 2.85
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 2.77
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 2.77
Effect of ILF3 on translation during homeostasis and the antiviral response 2.73
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 2.72
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 2.59
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 2.41
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.26
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 2.19
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 2.13
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 2.13
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 2.11
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 2.01
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.01
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 1.94
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 1.94
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 1.94
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 1.93
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.89
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 1.83
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 1.77
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.72
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.7
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.7
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.53
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 1.52
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 1.32
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 1.32
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.87
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.84
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 0.77
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.76
Gene expression profile of CRC-derived HILEC 0.76
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.52
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.52
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.48
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.44
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 0.41
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.41
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.27
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.26
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.2
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.15
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.09
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.09
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation